Company intelligence / Profile preview
Xi'an Wanlong Pharmaceutical
Xi'an, Shaanxi, Chinaxawanlong.com ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Xi'an Wanlong Pharmaceutical manufactures APIs, formulations, and intermediates, exporting both finished drugs and raw materials globally. The company holds GMP and DMF certifications and produces drugs for infections, diabetes complications, anesthesia, hypertension, and more. Clinical activities include bioequivalence and formulation studies for generics and finished dosage forms. Recent clinical studies include bioequivalence for bestatin capsules.
- Therapeutic areas
- EndocrinologyPsychiatryInfectious DiseasesCardiovascularOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Jilin Pharmaceutical Industry Design Institute
Beyond the preview
Go deeper on Xi'an Wanlong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xi'an Wanlong Pharmaceutical.